Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16

By Kowalczyk D.W.   Wlazlo A.P.   Shane S.   Ertl H.C.J.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3583-3590

Elsevier

Access to resources Recommend Favorite

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity

By Osen W.   Peiler T.   Ohlschlager P.   Caldeira S.   Faath S.   Michel N.   Muller M.   Tommasino M.   Jochmus I.   Gissmann L.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4276-4286

Elsevier

Access to resources Recommend Favorite

Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies

By Kawana K.   Kawana Y.   Yoshikawa H.   Taketani Y.   Yoshiike K.   Kanda T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1496-1502

Elsevier

Access to resources Recommend Favorite

The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles

By Greer C.E.   Petracca R.   Buonamassa D.T.   Di Tommaso A.   Gervase B.   Reeve R.L.   Ugozzoli M.   Van Nest G.   De Magistris M.T.   Bensi G.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1008-1012

Elsevier

Access to resources Recommend Favorite

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

By de Jong A.   O'Neill T.   Khan A.Y.   Kwappenberg K.M.C.   Chisholm S.E.   Whittle N.R.   Dobson J.A.   Jack L.C.   St Clair Roberts J.   Offringa R.   van der Burg S.H.   Hickling J.K.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3456-3464

Elsevier

Access to resources Recommend Favorite